State Street Europe Screened Index Equity Fund I

Reference Data

ISIN LU1159236337
Valor Number 29080967
Bloomberg Global ID
Fund Name State Street Europe Screened Index Equity Fund I
Fund Provider State Street Investment Management Kalanderplatz 5, 8045 Zürich
E-Mail: spdrsswitzerland@statestreet.com
Web: www.statestreet.com/im
spdrsswitzerland@statestreet.com (ETF Business)
Fund Provider State Street Investment Management
Representative in Switzerland State Street Bank GmbH, München, Zweigniederlassung Zürich
Zürich
Phone: +41 44 560 50 00
Distributor(s) State Street Global Advisors
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The objective of the Fund is to track the performance of the Eurozone equity markets.
Peculiarities

Fund Prices

Current Price * 21.03 EUR 30.10.2025
Previous Price * 21.05 EUR 29.10.2025
52 Week High * 21.06 EUR 24.10.2025
52 Week Low * 17.02 EUR 09.04.2025
NAV * 21.03 EUR 30.10.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 664,285,790
Unit/Share Assets *** 388,043,140
Trading Information SIX

Performance

YTD Performance +14.75% 31.12.2024
30.10.2025
YTD Performance (in CHF) +13.21% 31.12.2024
30.10.2025
1 month +3.23% 30.09.2025
30.10.2025
3 months +4.78% 30.07.2025
30.10.2025
6 months +9.69% 30.04.2025
30.10.2025
1 year +13.88% 30.10.2024
30.10.2025
2 years +37.58% 31.10.2023
30.10.2025
3 years +49.26% 31.10.2022
30.10.2025
5 years +88.87% 30.10.2020
30.10.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

ASML Holding NV 3.16%
SAP SE 2.30%
HSBC Holdings PLC 2.02%
Novartis AG Registered Shares 1.97%
Nestle SA 1.95%
AstraZeneca PLC 1.92%
Roche Holding AG 1.88%
Shell PLC 1.73%
Siemens AG 1.69%
Novo Nordisk AS Class B 1.45%
Last data update 30.09.2025

Cost / Risk

TER *** 0.25%
TER date *** 31.12.2023
Performance Fee ***
PTR
Max. Management Fee *** 0.20%
Ongoing Charges *** 0.25%
SRRI ***
SRRI date *** 30.09.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)